April 24, 20244Labor and Employment Lawyer Sydney Jones Lampard Joins King & Spalding in Washington, D.C.
April 24, 20244Hefesto Asesores continues to consolidate its position in the International Private Equity and Venture Capital market, with the formation of Hefesto Global
June 21, 20234Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture
June 19, 20234The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.
April 24, 20244Labor and Employment Lawyer Sydney Jones Lampard Joins King & Spalding in Washington, D.C.
Homepage North America North America Legal Chronicle Eli Lilly’s $1.4 Billion Acquisition of POINT Biopharma Eli Lilly’s $1.4 Billion Acquisition of POINT Biopharma October 6, 2023 Laura Testa Tagged: 10-6-2023 Asher Qazi Audrey Sokoloff Chadé Severin Eli Lilly and Company Elizabeth Malone Graham Robinson Joanna Schlingbaum Jorge Toledo Justine Haimi Keri Schick Norton Kirkland & Ellis Madison Moreland Maria Raptis Marissa Leonce Maya Florence megadeals Merric Kaufman Michael Nester Moshe Spinowitz Peter Fritz POINT Biopharma Global Resa Schlossberg Sarkis Jebejian Shellie Weisfield Freedman Skadden Sophia Hudson Steven Choi Timothy Nelson Kirkland & Ellis LLP is acting as legal counsel to Lilly, while Skadden, Arps, Slate, Meagher & Flom LLP is acting as legal counsel to POINT… This content is for Standard 1 Year members only.Login Join Now
